Yahoo
    NasdaqGM - Nasdaq Real Time Price USD

    Cronos Group Inc. (CRON)

    3.3000 -0.0600 (-1.79%)
    At close: October 30 at 4:00:01 PM EDT
    3.2600 -0.0400 (-1.21%)
    After hours: October 30 at 6:42:15 PM EDT
    Trade CRON on Coinbase
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for CRON
    • Previous Close 3.3600
    • Open 3.3500
    • Bid 2.4000 x 100
    • Ask 3.2400 x 100
    • Day's Range 3.2650 - 3.3579
    • 52 Week Range 2.2800 - 3.6080
    • Volume 1,071,702
    • Avg. Volume 1,133,551
    • Market Cap (intraday) 1.216B
    • Beta (5Y Monthly) 1.20
    • PE Ratio (TTM) 17.37
    • EPS (TTM) 0.1900
    • Earnings Date Nov 5, 2026
    • Forward Dividend & Yield -- (0.00%)
    • 1y Target Est 3.02
    • Zacks Rating Bullish

    Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

    thecronosgroup.com

    610

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Cronos Group Inc.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

    YTD Return

    CRON
    25.95%
    S&P/TSX Composite index (^GSPTSE)
    11.78%

    1-Year Return

    CRON
    35.25%
    S&P/TSX Composite index (^GSPTSE)
    18.03%

    3-Year Return

    CRON
    86.44%
    S&P/TSX Composite index (^GSPTSE)
    88.90%

    5-Year Return

    CRON
    36.42%
    S&P/TSX Composite index (^GSPTSE)
    69.32%

    Earnings Trends

    View More

    Earnings Per Share (GAAP)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q2 FY26
    Revenue 74.38M
    Earnings 45.02M
    Profit Margin 60.53%

    Q3

    FY25

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    0
    20M
    40M
    60M
    0.0%
    20.0%
    40.0%
    60.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    3.02 Low
    3.02 Average
    3.3000 Current
    3.02

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell

    Latest Rating

    Date 10/13/2026
    Analyst Zuanic & Associates
    Rating Action Initiated
    Rating Overweight
    Price Action --
    Price Target --
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      39.08%

    • Return on Assets (ttm)

      -0.10%

    • Return on Equity (ttm)

      7.05%

    • Revenue (ttm)

      179.09M

    • Net Income Avi to Common (ttm)

      69.98M

    • Diluted EPS (ttm)

      0.1900

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      797.02M

    • Total Debt/Equity (mrq)

      0.12%

    • Levered Free Cash Flow (ttm)

      6.11M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    CGC
    ACB
    TLRY
    OGI
    GTBIF
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: